We are live on ! Find out more
AA

Apriem Advisors Portfolio holdings

AUM $1.05B
1-Year Est. Return 22.09%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+22.09%
3 Year Est. Return
+62.04%
5 Year Est. Return
+69.09%
10 Year Est. Return
+243.72%
AUM
$667M
AUM Growth
+$41.9M
Cap. Flow
+$7.26M
Cap. Flow %
1.09%
Top 10 Hldgs %
49.91%
Holding
154
New
3
Increased
48
Reduced
56
Closed
11

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$1.49M
2
TSLA icon
Tesla
TSLA
+$1.43M
3
MMM icon
3M
MMM
+$1.1M
4
CTAS icon
Cintas
CTAS
+$634K
5
SCHF icon
Schwab International Equity ETF
SCHF
+$529K

Sector Composition

Rank Sector Weight
1 Technology 18.94%
2 Industrials 9.23%
3 Healthcare 7.36%
4 Energy 4.89%
5 Consumer Discretionary 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHB icon
26
Schwab US Broad Market ETF
SCHB
$42.3B
$7.39M 1.11%
428,643
SYK icon
27
Stryker
SYK
$135B
$6.24M 0.94%
20,447
-1,482
-7% -$428K
VWO icon
28
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$6.17M 0.93%
151,706
+11,773
+8% +$475K
SPYM
29
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$6.12M 0.92%
117,419
-975
-0.8% -$48.1K
MSFT icon
30
Microsoft
MSFT
$2.9T
$5.78M 0.87%
16,967
-94
-0.6% -$29.5K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.03M 0.75%
14,743
+779
+6% +$254K
QQQ icon
32
Invesco QQQ Trust
QQQ
$436B
$4.47M 0.67%
12,101
+17
+0.1% +$5.72K
ABBV icon
33
AbbVie
ABBV
$465B
$4.22M 0.63%
31,341
+6,757
+27% +$991K
JNJ icon
34
Johnson & Johnson
JNJ
$640B
$4.15M 0.62%
25,068
-271
-1% -$43.7K
TROW icon
35
T. Rowe Price
TROW
$25.5B
$4.07M 0.61%
36,289
-13,589
-27% -$1.49M
SCHD icon
36
Schwab US Dividend Equity ETF
SCHD
$104B
$3.75M 0.56%
154,710
+123
+0.1% +$2.94K
KLAC icon
37
KLA
KLAC
$222B
$3.51M 0.53%
72,360
-5,300
-7% -$221K
MMM icon
38
3M
MMM
$91.8B
$3.4M 0.51%
40,680
-12,909
-24% -$1.1M
VTIP icon
39
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$3.1M 0.47%
65,468
-8,999
-12% -$429K
BA icon
40
Boeing
BA
$169B
$3M 0.45%
14,227
+99
+0.7% +$20.6K
ABT icon
41
Abbott
ABT
$188B
$2.98M 0.45%
27,338
+5,874
+27% +$626K
SCHV
42
Schwab US Large-Cap Value ETF
SCHV
$15.6B
$2.97M 0.45%
133,017
-7,155
-5% -$156K
XLU icon
43
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
$2.95M 0.44%
90,100
IWF icon
44
iShares Russell 1000 Growth ETF
IWF
$117B
$2.76M 0.41%
40,108
+108
+0.3% +$6.87K
LOW icon
45
Lowe's Companies
LOW
$121B
$2.57M 0.39%
11,389
-535
-4% -$111K
PFE icon
46
Pfizer
PFE
$143B
$2.38M 0.36%
64,811
-108
-0.2% -$4.2K
GDX icon
47
VanEck Gold Miners ETF
GDX
$22.5B
$2.35M 0.35%
77,924
RSPT icon
48
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.31B
$2.14M 0.32%
72,940
+10
+0% +$273
AMD icon
49
Advanced Micro Devices
AMD
$700B
$2.11M 0.32%
18,490
-2,660
-13% -$277K
ED icon
50
Consolidated Edison
ED
$41.4B
$2.1M 0.31%
23,184
-52
-0.2% -$4.97K

Similar funds

Apriem Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Apriem Advisors held 154 positions worth $667M, up 6.7% from $625M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Apriem Advisors's Q2 2023 filing shows 3 new, 48 increased, 56 reduced and 11 closed positions. Its largest new stake was Vanguard Growth ETF: 6,066 shares worth $286K. The largest sale was T. Rowe Price, an estimated $1.49M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Apriem Advisors's largest Q2 2023 buy was Vanguard Growth ETF: 6,066 shares worth $286K.
  • Apriem Advisors added most to Schwab US Large- Cap ETF in Q2 2023, an estimated $6.55M increase.
  • Apriem Advisors's biggest Q2 2023 reduction was T. Rowe Price, cutting an estimated $1.49M.
  • Apriem Advisors fully exited Colgate-Palmolive in Q2 2023, selling an estimated $406K.
  • Apriem Advisors's ten largest holdings make up 50% of its $667M portfolio in Q2 2023.
  • Apriem Advisors opened 3 new positions and closed 11 in Q2 2023.
  • Apriem Advisors's portfolio value rose 6.7% quarter-over-quarter to $667M.

Based on Apriem Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.